Source: ERJ Open Res, 8 (1) 00630-2021; 10.1183/23120541.00630-2021



Rating:

Share or cite this content

Citations should be made in the following way:
Niranjan Jeganathan, Matheni Sathananthan. The prevalence and burden of interstitial lung diseases in the USA. ERJ Open Res, 8 (1) 00630-2021; 10.1183/23120541.00630-2021

Member's Comments

No comment yet.

Related content which might interest you: Incidence and prevalence of interstitial lung diseases in Greece Source: Eur Respir J 2005; 26: Suppl. 49, 266s Year: 2005 Spectrum of interstitial lung diseases (ILDs) and associated prevalence of pulmonary hypertension Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond Year: 2021 Prevalence and incidence of interstitial lung diseases (ILDs) in a French multi-ethnic county Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Comparison of registries of interstitial lung diseases in three European countries Source: Eur Respir J 2001; 18: 114S-118S Year: 2001 The burden of obstructive lung diseases Source: International Congress 2016 – PG1 Asthma and chronic obstructive pulmonary disease Year: 2016 The burden of obstructive lung diseases Source: International Congress 2015 – PG2 Asthma and COPD Year: 2015 The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype Source: Eur Respir Rev, 27 (150) 180077; 10.1183/16000617.0077-2018 Year: 2018 Incidence and prevalence of children’s diffuse lung disease in Spain. Source: Virtual Congress 2021 – Paediatric bronchology Year: 2021 Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Post-viral effects on the susceptibility of developing chronic lung diseases Source: Virtual Congress 2021 – Viral infections trigger chronic lung damage and disease Year: 2021 Interstitial lung diseases, mortality and associated risk factors Source: Eur Respir J 2004; 24: Suppl. 48, 667s Year: 2004 Relationship between lung function impairment and incidence or recurrence of cardiovascular disease in a middle-aged cohort Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD Year: 2007 The genetics of interstitial lung diseases Source: Eur Respir Rev, 28 (153) 190053; 10.1183/16000617.0053-2019 Year: 2019 Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Rare interstitial lung diseases of environmental origin Source: Eur Respir Mon 2011; 54: 301-316 Year: 2011 B-cell infiltration varies among patients with interstitial lung diseases Source: International Congress 2016 – ILD pathogenesis Year: 2016 Investigation burden in patients with fibrotic interstitial lung disease in their terminal admission Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments Year: 2018 Epidemiology of interstitial lung diseases. The RENIA study Source: Eur Respir J 2001; 18: Suppl. 33, 440s Year: 2001 The management of children with interstitial lung disease Source: International Congress 2018 – Difficult paediatric lung disease Year: 2018